AZITHROMYCIN INDUCES IN-VITRO A TIME-DEPENDENT INCREASE IN THE INTRACELLULAR KILLING OF STAPHYLOCOCCUS-AUREUS BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES WITHOUT DAMAGING PHAGOCYTES
M. Silvestri et al., AZITHROMYCIN INDUCES IN-VITRO A TIME-DEPENDENT INCREASE IN THE INTRACELLULAR KILLING OF STAPHYLOCOCCUS-AUREUS BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES WITHOUT DAMAGING PHAGOCYTES, Journal of antimicrobial chemotherapy, 36(6), 1995, pp. 941-950
Despite its clinical efficacy on intracellular pathogens, the in-vitro
intracellular antimicrobial activity of azithromycin, has been shown
to be absent or lower than expected from the intracellular concentrati
ons reached. To test the possibility that the high intracellular conce
ntrations of the drug could damage phagocytes, the present study evalu
ated the effects of azithromycin on (a) the intracellular killing of S
taphylococcus aureus by human blood neutrophils (PMNs) and (b) the via
bility and the respiratory burst of PMNs. Using a fluorochrome assay,
we assessed the phagocytosis and intracellular killing of S. aureus by
PMNs preloaded with azithromycin, or by PMNs unloaded but with the dr
ug in the culture medium. In addition, possible drug-induced damage to
PMNs was evaluated measuring: (a) hydrogen peroxide (H2O2) production
and (b) the percentages of PMNs dead at the end of the phagocytosis p
rocess. Compared to control PMNs without drug, a time-dependent enhanc
ement in the intracellular killing was observed which was statisticall
y significant after 60 min incubation. The increased intracellular kil
ling was higher in suspensions of unloaded PMNs and azithromycin (P <
0.01) that in suspensions of preloaded PMNs (P < 0.05). This increased
intracellular killing was not associated with increased proportions o
f dead phagocytes, either in preloaded or unloaded PMNs (P < 0.05, eac
h comparison). Similarly no changes in the production of H2O2 by PMNs
were observed in the presence of azithromycin. Thus, azithromycin indu
ces a time-dependent increase in the bactericidal activity of human PM
Ns, without increasing the phagocyte self-killing or modifying H2O2 pr
oduction.